Product Comparison

Comparison Options

• Print
• Email

McKesson #	974482	764549	666268
Description	Quadracel™ Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine 15 Lf - 5 Lf - 20 mcg - 62 DU / 0.5 mL Injection 0.5 mL	Kinrix® Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Inactivated Poliovirus Vaccine, Preservative Free 25 Lf - 10 Lf - 25 mcg - 80 DU / 0.5 mL Injection 0.5 mL	Kinrix® Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Inactivated Poliovirus Vaccine, Preservative Free 25 Lf - 10 Lf - 25 mcg - 80 DU / 0.5 mL Injection 0.5 mL
Manufacturer #	562-10	58160081252	58160081211
Brand	Quadracel™	Kinrix®	Kinrix®
Manufacturer	Sanofi Pasteur	Glaxo Smith Kline	Glaxo Smith Kline
Invoice	QUADRACEL, SDV 0.5ML (10/BX)	KINRIX VACCINE, SYR 25-25-10MG/0.5ML 0.5ML (10/PK)	KINRIX VACCINE, SDV 0.5ML (10/PK)
	Log In to Order	Log In to Order	Log In to Order
Comparison
Container Type	Single-Dose Vial	Prefilled Syringe	Single-Dose Vial
Country of Origin	Canada	Unknown	Unknown
Generic Drug Code	24543	99831	99830
Generic Drug Name	Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine	Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Inactivated Poliovirus Vaccine, Preservative Free	Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Inactivated Poliovirus Vaccine, Preservative Free
NDC Number	49281056210	58160081252	58160081211
Product Dating	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days
Strength	15 Lf - 5 Lf - 20 mcg - 62 DU / 0.5 mL	25 Lf - 10 Lf - 25 mcg - 80 DU / 0.5 mL	25 Lf - 10 Lf - 25 mcg - 80 DU / 0.5 mL
Application	DTaP and Polio Vaccine	DTaP and Polio Vaccine	DTaP and Polio Vaccine
Dosage Form	Injection	Injection	Injection
Storage Requirements	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration
Type	Intramuscular	Intramuscular	Intramuscular
UNSPSC Code	51202100	51202100	51202100
User	Indicated for People 4 to 6 Years of Age	Indicated for People 4 to 6 Years of Age	Indicated for People 4 to 6 Years of Age
Volume	0.5 mL	0.5 mL	0.5 mL
Features and Benefits	Quadracel is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis and poliomyelitis A single dose of Quadracel is approved for use in children 4 through 6 years of age as a fifth dose in the diphtheria, tetanus, pertussis vaccination (DTaP) series, and as a fourth or fifth dose in the inactivated poliovirus vaccination (IPV) series, in children who have received 4 doses of Pentacel and/or DAPTACEL vaccine Each 0.5 mL dose is formulated to contain 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, acellular pertussis antigens [20 mcg detoxified pertussis toxin (PT), 20 mcg filamentous hemagglutinin (FHA), 3 mcg pertactin (PRN), 5 mcg fimbriae types 2 and 3 (FIM)], and inactivated polioviruses [29 D-antigen units (DU) Type 1 (Mahoney), 7 DU Type 2 (MEF-1), 26 DU Type 3 (Saukett)]	KINRIX may be used for the fifth dose in the DTaP immunization series and the fourth dose in the IPV immunization series in children 4 through 6 years of age (prior to the seventh birthday) whose previous DTaP vaccine doses have been with INFANRIX and/or PEDIARIX for the first three doses and INFANRIX for the fourth dose Prefilled TIP-LOK syringe without needle Store refrigerated between 2 and 8 degrees C (36 and 46 degrees F) Each 0.5-mL dose is formulated to contain 25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated pertussis toxin (PT), 25 mcg of filamentous hemagglutinin (FHA), 8 mcg of pertactin (69 kiloDalton outer membrane protein), 40 D-antigen Units (DU) of Type 1 poliovirus (Mahoney), 8 DU of Type 2 poliovirus (MEF-1), and 32 DU of Type 3 poliovirus (Saukett)	KINRIX may be used for the fifth dose in the DTaP immunization series and the fourth dose in the IPV immunization series in children 4 through 6 years of age (prior to the seventh birthday) whose previous DTaP vaccine doses have been with INFANRIX and/or PEDIARIX for the first three doses and INFANRIX for the fourth dose Store refrigerated between 2 and 8 degrees C (36 and 46 degrees F) Each 0.5-mL dose is formulated to contain 25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated pertussis toxin (PT), 25 mcg of filamentous hemagglutinin (FHA), 8 mcg of pertactin (69 kiloDalton outer membrane protein), 40 D-antigen Units (DU) of Type 1 poliovirus (Mahoney), 8 DU of Type 2 poliovirus (MEF-1), and 32 DU of Type 3 poliovirus (Saukett)